(0.23%) 5 143.25 points
(0.10%) 38 481 points
(0.38%) 17 914 points
(-0.87%) $83.12
(1.09%) $1.944
(-0.09%) $2 345.00
(-0.05%) $27.52
(2.16%) $942.00
(-0.14%) $0.933
(-0.12%) $11.01
(-0.30%) $0.798
(1.66%) $93.40
-0.41% HKD 7.24
Live Chart Being Loaded With Signals
Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China...
Stats | |
---|---|
Tagesvolumen | 1.11M |
Durchschnittsvolumen | 752 134 |
Marktkapitalisierung | 8.59B |
EPS | HKD0 ( 2024-03-24 ) |
Nächstes Ertragsdatum | ( HKD0 ) 2024-05-27 |
Last Dividend | HKD0.205 ( 2023-05-30 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 15.74 |
ATR14 | HKD0.00600 (0.08%) |
Volumen Korrelation
Kangji Medical Holdings Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Kangji Medical Holdings Korrelation - Währung/Rohstoff
Kangji Medical Holdings Finanzdaten
Annual | 2023 |
Umsatz: | HKD926.02M |
Bruttogewinn: | HKD741.20M (80.04 %) |
EPS: | HKD0.430 |
FY | 2023 |
Umsatz: | HKD926.02M |
Bruttogewinn: | HKD741.20M (80.04 %) |
EPS: | HKD0.430 |
FY | 2022 |
Umsatz: | HKD786.37M |
Bruttogewinn: | HKD635.25M (80.78 %) |
EPS: | HKD0.400 |
FY | 2021 |
Umsatz: | HKD690.26M |
Bruttogewinn: | HKD562.93M (81.55 %) |
EPS: | HKD0.373 |
Financial Reports:
No articles found.
Kangji Medical Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.205 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0440 | 2021-05-28 |
Last Dividend | HKD0.205 | 2023-05-30 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | HKD0.421 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.1 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.32 | |
Div. Directional Score | 8.55 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6989.HK | Ex Dividend Junior | 2023-06-16 | Semi-Annually | 0 | 0.00% | |
1986.HK | Ex Dividend Junior | 2023-09-04 | Annually | 0 | 0.00% | |
1065.HK | Ex Dividend Junior | 2023-06-05 | Annually | 0 | 0.00% | |
0137.HK | No Dividend Player | 2023-06-01 | Sporadic | 0 | 0.00% | |
3613.HK | Ex Dividend Knight | 2023-05-10 | Annually | 0 | 0.00% | |
1606.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
0667.HK | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
9983.HK | Ex Dividend Junior | 2023-09-18 | Semi-Annually | 0 | 0.00% | |
2192.HK | Ex Dividend Junior | 2023-11-07 | Annually | 0 | 0.00% | |
1198.HK | No Dividend Player | 2023-07-21 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.544 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.118 | 1.200 | 6.06 | 7.27 | [0 - 0.3] |
returnOnEquityTTM | 0.138 | 1.500 | 9.58 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.429 | -1.000 | 5.71 | -5.71 | [0 - 1] |
currentRatioTTM | 17.72 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 15.27 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 14.03 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00888 | -1.500 | 9.85 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.359 | 2.00 | 9.88 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.284 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0104 | -1.500 | 9.96 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.800 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.478 | 1.000 | 2.44 | 2.44 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 11.08 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.217 | 0.800 | -1.885 | -1.508 | [0.5 - 2] |
Total Score | 11.78 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 15.77 | 1.000 | 8.51 | 0 | [1 - 100] |
returnOnEquityTTM | 0.138 | 2.50 | 9.73 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.284 | 2.00 | 9.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.02 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.359 | 2.00 | 9.88 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.429 | 1.500 | 5.71 | -5.71 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.453 | 1.000 | 1.172 | 0 | [0.1 - 0.5] |
Total Score | 5.32 |
Kangji Medical Holdings
Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.